| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 126.02B | 120.13B | 112.59B | 105.54B | 96.55B | 80.98B |
| Gross Profit | 56.28B | 55.25B | 51.17B | 43.70B | 42.34B | 35.15B |
| EBITDA | 26.13B | 25.07B | 22.08B | 16.66B | 14.78B | 10.27B |
| Net Income | 16.37B | 15.82B | 14.08B | 11.37B | 8.29B | 3.84B |
Balance Sheet | ||||||
| Total Assets | 134.84B | 132.48B | 112.49B | 97.61B | 89.11B | 85.37B |
| Cash, Cash Equivalents and Short-Term Investments | 27.00B | 29.03B | 18.61B | 11.34B | 2.77B | 778.00M |
| Total Debt | 7.03B | 4.80B | 2.65B | 1.83B | 6.05B | 10.37B |
| Total Liabilities | 50.72B | 51.44B | 41.28B | 37.62B | 40.37B | 44.78B |
| Stockholders Equity | 84.08B | 81.04B | 71.21B | 59.99B | 49.54B | 41.20B |
Cash Flow | ||||||
| Free Cash Flow | 8.50B | 17.85B | 10.20B | 4.78B | 8.43B | 16.44B |
| Operating Cash Flow | 9.39B | 19.47B | 11.18B | 6.15B | 9.77B | 18.18B |
| Investing Cash Flow | -4.52B | -11.14B | 2.26B | -550.00M | -3.13B | -992.00M |
| Financing Cash Flow | -9.56B | -5.57B | -4.07B | -5.00B | -6.88B | -17.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ₹908.28B | 61.38 | ― | 0.83% | 11.13% | 15.51% | |
65 Neutral | ₹369.79B | 71.27 | ― | 0.12% | 24.62% | 59.27% | |
57 Neutral | $3.13B | 9.23 | -34.32% | 3.14% | -25.56% | -353.61% | |
56 Neutral | ₹27.72B | 25.16 | ― | 0.28% | 2.36% | -26.16% |